West Pharmaceutical Services (WST): Rasio rega marang prakiraan pendapatan

Logo perusahaan publik West Pharma (WST)

The forward P/S multiple visualizes the link between the valuation of West Pharmaceutical Services (WST) and its high-tech manufacturing plants in Europe and the US. Price action relies on the production volumes of injectables within the biotech sector. 7.70 serves as the current parameter value, highlighting the company's dominance in the drug delivery systems niche, where stringent component certification makes switching suppliers virtually impossible.

West Pharmaceutical Services, Inc. - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep WST (periode 04.07.2022 - 15.11.2026)

Rincian analitis perusahaan westpharma.com (WST)

- rega saham lan target rega konsensus:
Analisis komprehensif perusahaan:West Pharma Corp (WST)
Produk sing diprodhuksi West Pharmaceutical Services

The market evaluates West Pharmaceutical Services (WST) through the lens of its hybrid production model's efficiency, where component outsourcing is combined with internal patent control. The forward P/S ratio compares current market capitalization with expected revenue, revealing whether the asset is overbought or if its potential is undervalued. Analysis of this chart allows for the identification of the investment risk point: an excessive increase in the ratio amid stagnating revenues signals an impending price correction.

Pesaing West Pharmaceutical Services (WST)

Rasio rega marang prakiraan pendapatan Intuitive Surgical Inc ISRG|Multiplikator Forward P/S Danaher Corporation Inc. DHR|BDX - Rasio rega marang prakiraan pendapatan|STERIS plc (STE) - Multiplikator forward rega marang pendapatan|BAX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Masimo|STVN (stevanatogroup.com) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan TFX (Teleflex Incorporated)|Rasio rega marang prakiraan pendapatan Merit Medical (MMSI)|Envista - Kapitalisasi marang prakiraan pendapatan|ICU Medical, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake XRAY (Dentsply Sirona Inc)|LMAT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake AtriCure Corp ATRC|staar.com (STAA) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan ChromaDex Corporation|ZIMV (ZimVie Inc) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan ANGO (AngioDynamics)|Rasio rega marang prakiraan pendapatan Cerus Corp (CERS)|TKNO: Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Monogram Technologies Inc. MGRM|Rega forward marang dodolan STSS|INFU - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan UTMD (Utah Medical Products Inc.)|KORU Medical Systems Inc. (KRMD) - Rasio rega marang prakiraan pendapatan|Nyxoah S.A. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Microbot Medical, Inc.|Kapitalisasi marang prakiraan pendapatan PDEX (Pro-Dex)|Rasio rega marang prakiraan pendapatan Zentek (ZTEK)|Rasio kapitalisasi marang dodolan sing dikarepake Elutia Inc|Multiplikator Forward P/S MLSS (milestonescientific.com)|NXGL: Kapitalisasi marang prakiraan pendapatan|Retractable Tech - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Harvard Bioscience Inc. HBIO|FEMY: Multiplikator Forward P/S|MeihuaMed - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Predictive Oncology Inc|callanjmb.com (CJMB) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Atrion Corporation (ATRI)|Rasio kapitalisasi marang dodolan sing dikarepake neurometrix.com